These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10083071)
1. Inhibition of complement reduces obliterative bronchiolitis. Kallio E; Lemström K; Ryan U; Häyry P; Koskinen P Transplant Proc; 1999; 31(1-2):188. PubMed ID: 10083071 [No Abstract] [Full Text] [Related]
2. Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor. Kallio E; Koskinen P; Buchdunger E; Lemström K Transplant Proc; 1999; 31(1-2):187. PubMed ID: 10083070 [No Abstract] [Full Text] [Related]
3. Cytomegalovirus infection accelerates experimental obliterative bronchiolitis via platelet-derived growth factor upregulation. Koskinen P; Kallio E; Tikkanen J; Bruggeman C; Häyry P; Lemström K Transplant Proc; 1997; 29(1-2):798. PubMed ID: 9123530 [No Abstract] [Full Text] [Related]
4. Blockade of complement inhibits obliterative bronchiolitis in rat tracheal allografts. Kallio EA; Lemström KB; Häyry PJ; Ryan US; Koskinen PK Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1332-9. PubMed ID: 10764331 [TBL] [Abstract][Full Text] [Related]
5. Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas. Qu N; de Vos P; Schelfhorst M; de Haan A; Timens W; Prop J J Heart Lung Transplant; 2005 Jul; 24(7):882-90. PubMed ID: 15982618 [TBL] [Abstract][Full Text] [Related]
6. A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts. Koskinen PK; Kallio EA; Krebs R; Lemström KB Am J Respir Crit Care Med; 1997 Jan; 155(1):303-12. PubMed ID: 9001329 [TBL] [Abstract][Full Text] [Related]
7. Tracheal allograft transplantation in rats: the role of immunosuppressive agents in development of obliterative airway disease. Yonan NA; Bishop P; el-Gamel A; Hutchinson IV Transplant Proc; 1998 Aug; 30(5):2207-9. PubMed ID: 9723443 [No Abstract] [Full Text] [Related]
8. Endothelin-1 is biologically active in experimental rat obliterative bronchiolitis. Pulkkinen VP; Tikkanen JM; Lemström KB; Koskinen PK Transplant Proc; 2001; 33(1-2):406. PubMed ID: 11266885 [No Abstract] [Full Text] [Related]
9. High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosis. Pham SM; Shears LL; Kawaharada N; Li S; Venkataramanan R; Sehgal S Transplant Proc; 1998 Jun; 30(4):953-4. PubMed ID: 9636385 [No Abstract] [Full Text] [Related]
10. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Hertz MI; Jessurun J; King MB; Savik SK; Murray JJ Am J Pathol; 1993 Jun; 142(6):1945-51. PubMed ID: 8506960 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model. Xu J; Torres E; Mora AL; Shim H; Ramirez A; Neujahr D; Brigham KL; Rojas M J Heart Lung Transplant; 2008 Dec; 27(12):1302-10. PubMed ID: 19059110 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor plays a major role in development of experimental obliterative bronchiolitis. Krebs R; Hollmén ME; Tikkanen JM; Wu Y; Hicklin DJ; Koskinen PK; Lemström KB Transplant Proc; 2006 Dec; 38(10):3266-7. PubMed ID: 17175244 [TBL] [Abstract][Full Text] [Related]
14. Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts. Ropponen JO; Syrjälä SO; Krebs R; Nykänen A; Tikkanen JM; Lemström KB J Heart Lung Transplant; 2011 Jun; 30(6):707-16. PubMed ID: 21411341 [TBL] [Abstract][Full Text] [Related]
15. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily]. Qi Z; Yang DY; Wang R; Wang SZ; Ping YM Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025 [TBL] [Abstract][Full Text] [Related]
16. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Boehler A; Chamberlain D; Kesten S; Slutsky AS; Liu M; Keshavjee S Transplantation; 1997 Jul; 64(2):311-7. PubMed ID: 9256193 [TBL] [Abstract][Full Text] [Related]
17. Administration of exogenous interleukin-2 enhances obliterative airway disease in cyclosporine-treated rats following tracheal allografts. Takao M; Gu Y; Shimamoto A; Adachi K; Namikawa S; Yada I Transplant Proc; 1999; 31(1-2):180-1. PubMed ID: 10083066 [No Abstract] [Full Text] [Related]
18. Rapamycin inhibits development of obliterative airway disease in a murine heterotopic airway transplant model. Fahrni JA; Berry GJ; Morris RE; Rosen GD Transplantation; 1997 Feb; 63(4):533-7. PubMed ID: 9047146 [TBL] [Abstract][Full Text] [Related]
19. Intestinal transplantation in the mouse. Zhong R; Zhang Z; Quan D; Garcia B; Duff J; Stiller C; Grant D Transplantation; 1993 Oct; 56(4):1034-7. PubMed ID: 8212187 [No Abstract] [Full Text] [Related]
20. Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model. Yamada A; Konishi K; Cruz GL; Takehara M; Morikawa M; Nakagawa I; Murakami M; Abe T; Todo S; Uede T Transplantation; 2000 Mar; 69(5):743-9. PubMed ID: 10755520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]